Boswellia for urinary symptoms during prostate cancer radiation
Part of Cancer, Kidney & urinary clinical trials.
This study tests whether a natural supplement called Boswellia can help reduce urinary side effects during radiation therapy for prostate cancer. It may help people who are already experiencing worsening urinary symptoms from their treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer and are currently receiving radiation therapy (or have had radiation to the prostate area after surgery).
- You are having worsening urinary symptoms from the radiation, like pain or trouble urinating.
- You have at least 1 week of radiation treatments left before you join.
- You are 18 years or older.
- You can read and speak English, or can use an interpreter, and can give written consent.
- You cannot have already started a new medicine for urinary symptoms during this radiation course.
- You must not have moderate to severe liver disease, and you must not be allergic to Boswellia or unable to swallow pills.
- You cannot be taking certain medications that could interact with Boswellia (like some antibiotics, antifungals, seizure medicines, or St. John's wort).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a daily drink can help reduce bowel side effects caused by radiation for prostate cancer. If you are about to start radiation for intermediate to high-risk prostate cancer, you may be able to join.
This trial tests whether adding hormone therapy (ADT) to stereotactic body radiation therapy (SBRT) works better than SBRT alone for men with a specific type of prostate cancer called 'unfavorable intermediate risk.' The goal is to see if the combination helps control the cancer better.
This trial tests whether taking CoQ10 and vitamin E supplements can reduce the side effects of radiation therapy for certain cancers. If you are receiving radiation for prostate, uterine, or anal cancer, this study might help you manage treatment-related symptoms.
This study tests a tailored (personalized) radiation plan for men whose PSA (“prostate blood test”) rises after prostate surgery but who have no detectable spread on scans. It may help control cancer growth by targeting the right area based on your situation.
This trial tests whether adding a new drug (saruparib) to standard radiation and hormone therapy can help prevent prostate cancer from spreading to other parts of the body. It is for men with high-risk prostate cancer that has a BRCA gene mutation.
This study follows people with prostate cancer who receive radiation to understand what side effects and quality-of-life changes happen over time. It may help improve standard follow-up care by better tracking radiation-related toxicity.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.